Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: A prospective investigator‐blinded study
Peter Faybik, Claus‐Georg Krenn, Amir Baker, Daniel Lahner, Gabriela Berlakovich, Heinz Steltzer, Hubert Hetz – 23 July 2004 – Plasma disappearance rate of indocyanine green (PDRICG) has been proposed for assessment of liver function in liver transplants donors and recipients, in patients with chronic liver failure, and as a prognostic factor in critically ill patients. The assessment of PDRICG using a newly developed noninvasive digital pulse densitometry method was simultaneously compared to invasive aortic fiber‐optic method in patients undergoing orthotopic liver transplantation (OLT).
Outcome of liver transplantation for hepatitis B in the United States
W. Ray Kim, John J. Poterucha, Walter K. Kremers, Michael B. Ishitani, E. Rolland Dickson – 23 July 2004 – Important innovations, such as hepatitis B immune globulin (HBIG) and lamivudine, have been introduced to the care of patients undergoing liver transplantation (OLT) for viral hepatitis B (HBV) (over the last 15 years). We analyzed survival of OLT recipients with HBV in the United States to examine the effect of these innovations.
Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation
James F. Trotter, Brad Brimhall, Russ Arjal, Charles Phillips – 23 July 2004 – Priority for liver transplantation is currently based on the Model for Endstage Liver Disease (MELD) score, a mathematical function which includes the following objective variables: bilirubin, creatinine (Cr), and international normalized ratio (INR). We have noted that specific laboratory methodologies may yield consistently higher values of bilirubin, Cr, and INR.
Volumetric and functional recovery of the liver after right hepatectomy for living donation
Silvio Nadalin, Giuliano Testa, Massimo Malagó, Mechtild Beste, Andrea Frilling, Thobias Schroeder, Christoph Jochum, Guido Gerken, Christoph E. Broelsch – 23 July 2004 – Our objective was to study the kinetics of recovery of the liver volume and liver function after right hepatectomy (RH) for living donation, comparing conventional and quantitative liver function tests, i.e., galactose elimination capacity (GEC). A total of 27 donors underwent RH averaging 61% of the whole liver volume.
Liver regeneration after adult living donor and deceased donor split‐liver transplants
Zakiyah Kadry, Nazia Selzner, Markus Selzner, Pierre‐Alain Clavien – 23 July 2004
Heterogeneity in liver allocation
Richard Freeman – 23 July 2004
Recurrent sclerosing cholangitis or ischemic bile duct lesions—A diagnostic challenge?
Bjørn Brandsaeter, Erik Schrumpf, Ole Petter Clausen, Andreas Abildgaard, Geir Hafsahl, Kristian Bjøro – 23 July 2004
Acute renal failure after liver transplantation: The role of dopamine and fenoldopam
- Read more about Acute renal failure after liver transplantation: The role of dopamine and fenoldopam
Nelson Leung, Stephen C. Textor – 23 July 2004
Older age and liver transplantation: A review
Rajesh N. Keswani, Aijaz Ahmed, Emmet B. Keeffe – 23 July 2004 – Patients older than 60 are undergoing transplantation with increasing frequency. Reports from several transplant centers document that overall short‐term patient survival rates in seniors undergoing liver transplantation are comparable to survival rates of younger adults. However, specific subgroups of older patients may not fare as well. Seniors with far‐advanced end‐stage liver disease are high‐risk for liver transplantation and have poor survival rates.